MedTrace Logo

Home Sleep and Circadian Phase: Mediators of Diabetes Risk

NCT01786564 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2020-11-27

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if deficient sleep and/or disruption with the body's internal clock ("circadian rhythms") are associated with diabetes risk. This study is being done to look at the possible relationships between sleep and risk of diabetes by examining sleep in the home and diabetes risk in the laboratory.

Conditions

  • Sleep Deprivation
  • Diabetes
  • Circadian Dysregulation

Sponsors & Collaborators

Principal Investigators

  • Kristen Knuston, PhD · Northwestern University

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-12-06
Primary Completion
2019-09-30
Completion
2019-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01786564 on ClinicalTrials.gov